Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2004-09-29
2011-11-29
Andres, Janet (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C514S357000
Reexamination Certificate
active
08067608
ABSTRACT:
Aromatic compounds for treating various diseases and pathologies are disclosed. The methods use of such compounds are also provided. Accordingly, the present invention makes available methods and compositions for inhibiting aberrant growth states resulting from hedgehog gain-of-function, ptc loss-of-function or smoothened gain-of-function.
REFERENCES:
patent: WO 2004056774 (2004-07-01), None
Hcaplus 109:73373.
Hcaplus 1999:48617.
Patani, George, et. al., “Bioisosterism: A Rational Approach in Drug Design”, Chem. Rev. 1996, 3147-3176.
HCAPLUS 109:73373 1988.
Patani, George, et. al., “Bioisosterism: A Rational Approach in Drug Design”, Chem. Rev. , 3147-3176, 1996.
Hcaplus 1999:48617, “Preparation of N-[(aminoalkoxy)phenyl]benezamides and analogs as CCR5 receptor ligands”, Bondinell et. al., WO 9901127, Nov. 4, 1999.
Beachy Philip A.
Chen James K.
Taipale Anssi J.
Andres Janet
DLA Piper (LLP) US
Reese Heidi
The Johns Hopkins University
LandOfFree
Hedgehog pathway antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hedgehog pathway antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hedgehog pathway antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4310055